Galectin Therapeutics
GALT
#8075
Rank
NZ$0.27 B
Marketcap
$4.45
Share price
1.48%
Change (1 day)
38.79%
Change (1 year)

Market capitalization of Galectin Therapeutics (GALT)

Market cap: NZ$0.27 Billion

As of September 2024 Galectin Therapeutics has a market cap of NZ$0.27 Billion. This makes Galectin Therapeutics the world's 8075th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Galectin Therapeutics from 2002 to 2024

End of year Market Cap

Year Market cap Change
2024NZ$0.27 B70.51%
2023NZ$0.16 B53.5%
2022NZ$0.10 B-41.03%
2021NZ$0.17 B0.9%
2020NZ$0.17 B-26.3%
2019NZ$0.24 B14.58%
2018NZ$0.21 B25.61%
2017NZ$0.16 B267.86%
2016NZ$45.56 M-34.11%
2015NZ$69.14 M-29.83%
2014NZ$98.54 M-45.53%
2013NZ$0.18 B350.43%
2012NZ$40.15 M-57.63%
2011NZ$94.78 M26.63%
2010NZ$74.85 M272.52%
2009NZ$20.09 M168.63%
2008NZ$7.48 M-79.54%
2007NZ$36.56 M76.05%
2006NZ$20.77 M-82.96%
2005NZ$0.12 B27.36%
2004NZ$95.7 M-34.59%
2003NZ$0.14 B38.72%
2002NZ$0.10 B

End of Day market cap according to different sources

On Sep 29th, 2024 the market cap of Galectin Therapeutics was reported to be:

NZ$0.27 Billion
by Yahoo Finance info icon info icon
NZ$0.27 Billion
by CompaniesMarketCap info icon info icon
NZ$0.27 Billion
by Nasdaq info icon info icon

Market capitalization for similar companies or competitors

Name Market cap Market cap differencediff. Country
NZ$6.65 B 2,304.27%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$2.79 B 909.97%๐Ÿ‡บ๐Ÿ‡ธ USA